Grant is the Chief Business Officer with Bolt BioTherapeutics. Bolt Bio recently went public in February this year and announced a partnership with Genmab. Grant talks business development strategy and helping to navigate Bolt through their recent milestones. Bolt Bio focuses on the development of ISACs – immune-stimulating antibody conjugates – which are anti-cancer drugs […]

James Mackay, President & CEO, Aristea Therapeutics, serves as an independent board member to two other San Diego-based biopharma companies: Arthrosi Therapeutics and MatriSys Bioscience, and Peabody, MA-based Privo Technologies. What exactly is an independent board member? Mackay keeps it simple: A board member with no (or limited) vested financial interest in the company they’ve been asked to guide.

On June 3, 2021, five biopharma executives and one intellectual property attorney joined Pharmaceutical Executive to discuss collaboration within the industry, a topic that has come front and center since the start of the pandemic. Participants shared their insights on what they feel are some of the most important and pressing collaboration issues in pharma today and […]